Loading…

Comparison of the effects of cyclosporine A and trimetazidine on Ca2+-dependent mitochondrial swelling

Summary— Cyclosporine A (CsA) is a known potent inhibitor of pro‐oxidant‐induced mitochondrial swelling. In the present study we show that CsA's effect is only transient when the liver mitochondrial swelling is induced by Ca2+ plus tert‐butylhydroperoxide (t‐BH). After an initial inhibition, sw...

Full description

Saved in:
Bibliographic Details
Published in:Fundamental & clinical pharmacology 1997-09, Vol.11 (5), p.440-447
Main Authors: Elimadi, A., Morin, D., Sapena, R., Chauvet-Monges, AM, Crevat, A., Tillement, JP
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 447
container_issue 5
container_start_page 440
container_title Fundamental & clinical pharmacology
container_volume 11
creator Elimadi, A.
Morin, D.
Sapena, R.
Chauvet-Monges, AM
Crevat, A.
Tillement, JP
description Summary— Cyclosporine A (CsA) is a known potent inhibitor of pro‐oxidant‐induced mitochondrial swelling. In the present study we show that CsA's effect is only transient when the liver mitochondrial swelling is induced by Ca2+ plus tert‐butylhydroperoxide (t‐BH). After an initial inhibition, swelling is worsened by CsA as evidenced by an extent of mitochondrial swelling that exceeds that of the control. Unlike CsA, trimetazidine (TMZ), an anti‐ischemic drug decreases both the extent and the rate of the swelling with an IC50 value of 214 ± 24 μM. Its inhibition effect on the initial swelling rate mimicks that of CsA but the mechanism may be independent. During long‐term swelling, TMZ counteracts the worsening effect of CsA. The inhibition of swelling induced by TMZ is assessed by the fact that TMZ significantly increases the EC50 of Ca2+‐induced mitochondrial swelling (46.6 ± 6.0 to 85 ± 10 μM, P < 0.01), without affecting its cooperativity. Apparently, TMZ seems to behave like trifluoperazine (TIT), a phospholipase A2 inhibitor that, under our experimental conditions, inhibits the mitochondrial swelling induced by Ca2+ and t‐BH with an IC50 value of 25 ± 10 μM. Both drugs are able to protect mitochondria from both phases (early and late) of the swelling, especially the late, which is enhanced in the presence of CsA. TFP and other phospholipase A2 inhibitors were able to displace [3H]TMZ from its mitochondrial binding sites whereas CsA was ineffective. We suggest that TMZ, like TFP, inhibits the CsA insensitive mechanism involved in the swelling process which is responsible for the worsening effect observed in the presence of CsA when the swelling is generated by Ca2+ and t‐BH.
doi_str_mv 10.1111/j.1472-8206.1997.tb00206.x
format article
fullrecord <record><control><sourceid>wiley_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2812572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FCP206</sourcerecordid><originalsourceid>FETCH-LOGICAL-i2076-40201c116e0079330bae0d12cc8b3f62b07af9f9fcf7b84a360ad46e1baf82d53</originalsourceid><addsrcrecordid>eNo9kF9LwzAUxYMoOKffoYhv0nqTdkn7IszipjB0iOJjSPPHZXZpaQrb_PSmbCx5yL255x4OP4RuMSQ4nId1gjNG4pwATXBRsKSvAIZmd4ZGp9E5GgGjLE6LHF-iK-_XAJgBpiNkymbTis76xkWNifqVjrQxWvZ-aOVe1o1vm846HU0j4VTUd3aje_Fn1fAXtkpB7mOlW-2Udn20sX0jV41TnRV15Le6rq37uUYXRtRe3xzfMfqaPX-WL_Hiff5aThexJSFhnIXsWGJMNQAr0hQqoUFhImVepYaSCpgwRbjSsCrPREpBqIxqXAmTEzVJx-ju4NsKL0VtOuGk9bwNoUW35yTHZMJIkD0eZFtb6_1pjIEPVPmaD-j4gI4PVPmRKt_xWbkMRTCIDwbW93p3MhDdL6csZRP-_Tbn-QQYzJdP_CP9BwqTflc</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparison of the effects of cyclosporine A and trimetazidine on Ca2+-dependent mitochondrial swelling</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Elimadi, A. ; Morin, D. ; Sapena, R. ; Chauvet-Monges, AM ; Crevat, A. ; Tillement, JP</creator><creatorcontrib>Elimadi, A. ; Morin, D. ; Sapena, R. ; Chauvet-Monges, AM ; Crevat, A. ; Tillement, JP</creatorcontrib><description>Summary— Cyclosporine A (CsA) is a known potent inhibitor of pro‐oxidant‐induced mitochondrial swelling. In the present study we show that CsA's effect is only transient when the liver mitochondrial swelling is induced by Ca2+ plus tert‐butylhydroperoxide (t‐BH). After an initial inhibition, swelling is worsened by CsA as evidenced by an extent of mitochondrial swelling that exceeds that of the control. Unlike CsA, trimetazidine (TMZ), an anti‐ischemic drug decreases both the extent and the rate of the swelling with an IC50 value of 214 ± 24 μM. Its inhibition effect on the initial swelling rate mimicks that of CsA but the mechanism may be independent. During long‐term swelling, TMZ counteracts the worsening effect of CsA. The inhibition of swelling induced by TMZ is assessed by the fact that TMZ significantly increases the EC50 of Ca2+‐induced mitochondrial swelling (46.6 ± 6.0 to 85 ± 10 μM, P &lt; 0.01), without affecting its cooperativity. Apparently, TMZ seems to behave like trifluoperazine (TIT), a phospholipase A2 inhibitor that, under our experimental conditions, inhibits the mitochondrial swelling induced by Ca2+ and t‐BH with an IC50 value of 25 ± 10 μM. Both drugs are able to protect mitochondria from both phases (early and late) of the swelling, especially the late, which is enhanced in the presence of CsA. TFP and other phospholipase A2 inhibitors were able to displace [3H]TMZ from its mitochondrial binding sites whereas CsA was ineffective. We suggest that TMZ, like TFP, inhibits the CsA insensitive mechanism involved in the swelling process which is responsible for the worsening effect observed in the presence of CsA when the swelling is generated by Ca2+ and t‐BH.</description><identifier>ISSN: 0767-3981</identifier><identifier>EISSN: 1472-8206</identifier><identifier>DOI: 10.1111/j.1472-8206.1997.tb00206.x</identifier><identifier>CODEN: FCPHEZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Biological and medical sciences ; calcium ; cyclosporine A ; Digestive system ; Drug toxicity and drugs side effects treatment ; Medical sciences ; mitochondrial swelling ; Pharmacology. Drug treatments ; tert-butylhydroperoxide ; Toxicity: digestive system ; trimetazidine</subject><ispartof>Fundamental &amp; clinical pharmacology, 1997-09, Vol.11 (5), p.440-447</ispartof><rights>1997 Société Française de Pharmacologie et de Thérapeutique</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2812572$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Elimadi, A.</creatorcontrib><creatorcontrib>Morin, D.</creatorcontrib><creatorcontrib>Sapena, R.</creatorcontrib><creatorcontrib>Chauvet-Monges, AM</creatorcontrib><creatorcontrib>Crevat, A.</creatorcontrib><creatorcontrib>Tillement, JP</creatorcontrib><title>Comparison of the effects of cyclosporine A and trimetazidine on Ca2+-dependent mitochondrial swelling</title><title>Fundamental &amp; clinical pharmacology</title><description>Summary— Cyclosporine A (CsA) is a known potent inhibitor of pro‐oxidant‐induced mitochondrial swelling. In the present study we show that CsA's effect is only transient when the liver mitochondrial swelling is induced by Ca2+ plus tert‐butylhydroperoxide (t‐BH). After an initial inhibition, swelling is worsened by CsA as evidenced by an extent of mitochondrial swelling that exceeds that of the control. Unlike CsA, trimetazidine (TMZ), an anti‐ischemic drug decreases both the extent and the rate of the swelling with an IC50 value of 214 ± 24 μM. Its inhibition effect on the initial swelling rate mimicks that of CsA but the mechanism may be independent. During long‐term swelling, TMZ counteracts the worsening effect of CsA. The inhibition of swelling induced by TMZ is assessed by the fact that TMZ significantly increases the EC50 of Ca2+‐induced mitochondrial swelling (46.6 ± 6.0 to 85 ± 10 μM, P &lt; 0.01), without affecting its cooperativity. Apparently, TMZ seems to behave like trifluoperazine (TIT), a phospholipase A2 inhibitor that, under our experimental conditions, inhibits the mitochondrial swelling induced by Ca2+ and t‐BH with an IC50 value of 25 ± 10 μM. Both drugs are able to protect mitochondria from both phases (early and late) of the swelling, especially the late, which is enhanced in the presence of CsA. TFP and other phospholipase A2 inhibitors were able to displace [3H]TMZ from its mitochondrial binding sites whereas CsA was ineffective. We suggest that TMZ, like TFP, inhibits the CsA insensitive mechanism involved in the swelling process which is responsible for the worsening effect observed in the presence of CsA when the swelling is generated by Ca2+ and t‐BH.</description><subject>Biological and medical sciences</subject><subject>calcium</subject><subject>cyclosporine A</subject><subject>Digestive system</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Medical sciences</subject><subject>mitochondrial swelling</subject><subject>Pharmacology. Drug treatments</subject><subject>tert-butylhydroperoxide</subject><subject>Toxicity: digestive system</subject><subject>trimetazidine</subject><issn>0767-3981</issn><issn>1472-8206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNo9kF9LwzAUxYMoOKffoYhv0nqTdkn7IszipjB0iOJjSPPHZXZpaQrb_PSmbCx5yL255x4OP4RuMSQ4nId1gjNG4pwATXBRsKSvAIZmd4ZGp9E5GgGjLE6LHF-iK-_XAJgBpiNkymbTis76xkWNifqVjrQxWvZ-aOVe1o1vm846HU0j4VTUd3aje_Fn1fAXtkpB7mOlW-2Udn20sX0jV41TnRV15Le6rq37uUYXRtRe3xzfMfqaPX-WL_Hiff5aThexJSFhnIXsWGJMNQAr0hQqoUFhImVepYaSCpgwRbjSsCrPREpBqIxqXAmTEzVJx-ju4NsKL0VtOuGk9bwNoUW35yTHZMJIkD0eZFtb6_1pjIEPVPmaD-j4gI4PVPmRKt_xWbkMRTCIDwbW93p3MhDdL6csZRP-_Tbn-QQYzJdP_CP9BwqTflc</recordid><startdate>19970910</startdate><enddate>19970910</enddate><creator>Elimadi, A.</creator><creator>Morin, D.</creator><creator>Sapena, R.</creator><creator>Chauvet-Monges, AM</creator><creator>Crevat, A.</creator><creator>Tillement, JP</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope></search><sort><creationdate>19970910</creationdate><title>Comparison of the effects of cyclosporine A and trimetazidine on Ca2+-dependent mitochondrial swelling</title><author>Elimadi, A. ; Morin, D. ; Sapena, R. ; Chauvet-Monges, AM ; Crevat, A. ; Tillement, JP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i2076-40201c116e0079330bae0d12cc8b3f62b07af9f9fcf7b84a360ad46e1baf82d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>calcium</topic><topic>cyclosporine A</topic><topic>Digestive system</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Medical sciences</topic><topic>mitochondrial swelling</topic><topic>Pharmacology. Drug treatments</topic><topic>tert-butylhydroperoxide</topic><topic>Toxicity: digestive system</topic><topic>trimetazidine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elimadi, A.</creatorcontrib><creatorcontrib>Morin, D.</creatorcontrib><creatorcontrib>Sapena, R.</creatorcontrib><creatorcontrib>Chauvet-Monges, AM</creatorcontrib><creatorcontrib>Crevat, A.</creatorcontrib><creatorcontrib>Tillement, JP</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><jtitle>Fundamental &amp; clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elimadi, A.</au><au>Morin, D.</au><au>Sapena, R.</au><au>Chauvet-Monges, AM</au><au>Crevat, A.</au><au>Tillement, JP</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the effects of cyclosporine A and trimetazidine on Ca2+-dependent mitochondrial swelling</atitle><jtitle>Fundamental &amp; clinical pharmacology</jtitle><date>1997-09-10</date><risdate>1997</risdate><volume>11</volume><issue>5</issue><spage>440</spage><epage>447</epage><pages>440-447</pages><issn>0767-3981</issn><eissn>1472-8206</eissn><coden>FCPHEZ</coden><abstract>Summary— Cyclosporine A (CsA) is a known potent inhibitor of pro‐oxidant‐induced mitochondrial swelling. In the present study we show that CsA's effect is only transient when the liver mitochondrial swelling is induced by Ca2+ plus tert‐butylhydroperoxide (t‐BH). After an initial inhibition, swelling is worsened by CsA as evidenced by an extent of mitochondrial swelling that exceeds that of the control. Unlike CsA, trimetazidine (TMZ), an anti‐ischemic drug decreases both the extent and the rate of the swelling with an IC50 value of 214 ± 24 μM. Its inhibition effect on the initial swelling rate mimicks that of CsA but the mechanism may be independent. During long‐term swelling, TMZ counteracts the worsening effect of CsA. The inhibition of swelling induced by TMZ is assessed by the fact that TMZ significantly increases the EC50 of Ca2+‐induced mitochondrial swelling (46.6 ± 6.0 to 85 ± 10 μM, P &lt; 0.01), without affecting its cooperativity. Apparently, TMZ seems to behave like trifluoperazine (TIT), a phospholipase A2 inhibitor that, under our experimental conditions, inhibits the mitochondrial swelling induced by Ca2+ and t‐BH with an IC50 value of 25 ± 10 μM. Both drugs are able to protect mitochondria from both phases (early and late) of the swelling, especially the late, which is enhanced in the presence of CsA. TFP and other phospholipase A2 inhibitors were able to displace [3H]TMZ from its mitochondrial binding sites whereas CsA was ineffective. We suggest that TMZ, like TFP, inhibits the CsA insensitive mechanism involved in the swelling process which is responsible for the worsening effect observed in the presence of CsA when the swelling is generated by Ca2+ and t‐BH.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/j.1472-8206.1997.tb00206.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0767-3981
ispartof Fundamental & clinical pharmacology, 1997-09, Vol.11 (5), p.440-447
issn 0767-3981
1472-8206
language eng
recordid cdi_pascalfrancis_primary_2812572
source Wiley-Blackwell Read & Publish Collection
subjects Biological and medical sciences
calcium
cyclosporine A
Digestive system
Drug toxicity and drugs side effects treatment
Medical sciences
mitochondrial swelling
Pharmacology. Drug treatments
tert-butylhydroperoxide
Toxicity: digestive system
trimetazidine
title Comparison of the effects of cyclosporine A and trimetazidine on Ca2+-dependent mitochondrial swelling
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A16%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20effects%20of%20cyclosporine%20A%20and%20trimetazidine%20on%20Ca2+-dependent%20mitochondrial%20swelling&rft.jtitle=Fundamental%20&%20clinical%20pharmacology&rft.au=Elimadi,%20A.&rft.date=1997-09-10&rft.volume=11&rft.issue=5&rft.spage=440&rft.epage=447&rft.pages=440-447&rft.issn=0767-3981&rft.eissn=1472-8206&rft.coden=FCPHEZ&rft_id=info:doi/10.1111/j.1472-8206.1997.tb00206.x&rft_dat=%3Cwiley_pasca%3EFCP206%3C/wiley_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i2076-40201c116e0079330bae0d12cc8b3f62b07af9f9fcf7b84a360ad46e1baf82d53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true